url:https://finance.yahoo.com/news/gilead-sciences-present-upcoming-investor-001300301.html
title:Gilead_Sciences_to_Present_at_Upcoming_Investor_Conferences
FOSTER CITY, Calif., November 09, 2023--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:
Jefferies London Healthcare Conference on Wednesday, November 15 at 9:00am Greenwich Mean Time
Evercore ISI HealthCONx Conference on Tuesday, November 28 at 1:20pm Eastern Time
Piper Sandler Healthcare Conference on Wednesday, November 29 at 9:00am Eastern Time
The live webcasts can be accessed at the company’s investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231108938335/en/
Contacts
Jacquie Ross, CFA – Investorsinvestor_relations@gilead.com
Related Quotes